Salix's Xifaxan for hepatic encephalopathy passed advisory committee review, but members expressed unease about lingering safety concerns and called for additional studies. read_more_>
Continue reading "Latest News from "The Pink Sheet" DAILY - Salix's Xifaxan Advisory Panel Review" »
The complaint says J&J paid Omnicare rebates to intervene in physician prescribing and sought to keep "best prices" down by substituting rebate payments for the purchase of Omnicare data.
read more
Continue reading "Latest News from "The Pink Sheet" DAILY" »
Pharma industry is providing aid to Haiti: Abbott is contributing $1 million in grant funding and donations of pharmaceutical and nutritional products and Amgen is donating $2 million. Johnson & Johnson immediately shipped large quantities of its products and Lilly and Pfizer are among others providing medicines and financial assistance.
Continue reading "Coming in Friday's "The Pink Sheet" DAILY" »
In the latest move to divest parts of its business in the wake of a financing crisis, India’s Wockhardt has sold ten hospitals to Fortis Healthcare. For in-depth analysis of this deal, see today’s interview on CNBC TV-18 with PharmAsia News India Bureau Chief Vikas Dandekar.
For background on Wockhardt’s recent financial struggles, see the PharmAsia News story, below, from July 29 analyzing Wockhardt’s recent deal with Abbott. Read more here...
Continue reading "Direct from India: Fortis Acquires Hospitals from Wockhardt" »